Almeida F A, Suzuki M, Scarborough R M, Lewicki J A, Maack T
Department of Physiology, Cornell University Medical College, New York, New York 10021.
Am J Physiol. 1989 Feb;256(2 Pt 2):R469-75. doi: 10.1152/ajpregu.1989.256.2.R469.
The overwhelming majority of atrial natriuretic factor (ANF) receptors in kidney and vascular tissues do not mediate any of the known functional effects of the hormone. To test whether these receptors (C-ANF receptors) function as clearance receptors for circulating ANF-(1-28), we determined the effects of C-ANF-(4-23) [des[Gln18Ser19Gly20Leu21Gly22]rANF-(3-23)-NH2], a specific ligand of C-ANF receptors, on the pharmacokinetics and hydrolysis of 125I-labeled ANF-(1-28) in anesthetized rats. Radioactivity in plasma was characterized by trichloroacetic acid solubility and high-pressure liquid chromatography. C-ANF-(4-23) (1 and 10 micrograms.min-1.kg body wt-1) led to marked dose-dependent increases in initial plasma concentration of administered 125I-ANF-(1-28) and decreases in its volume of distribution at steady state (Vss), metabolic clearance rate (MCR), and appearance of hydrolytic products ([125I]monoiodotyrosine and free 125I) in plasma (Pm). At the highest dose, C-ANF-(4-23) decreased Vss from 97 +/- 12 to 36 +/- 2 ml/100 g body wt, MCR from 50 +/- 4 to 12 +/- 1 ml.min-1.100 g body wt-1, and Pm from 54 +/- 8 to 11 +/- 2% of initial plasma 125I-ANF-(1-28). The data demonstrate that C-ANF receptors are mainly responsible for the very large volume of distribution and fast MCR of ANF in the rat. In this manner, C-ANF receptors are likely to play an important role in the homeostasis of circulating ANF.
肾脏和血管组织中绝大多数心房利钠因子(ANF)受体并不介导该激素的任何已知功能效应。为了检测这些受体(C-ANF受体)是否作为循环ANF-(1-28)的清除受体发挥作用,我们测定了C-ANF受体的特异性配体C-ANF-(4-23) [des[Gln18Ser19Gly20Leu21Gly22]rANF-(3-23)-NH2]对麻醉大鼠体内125I标记的ANF-(1-28)药代动力学和水解的影响。血浆中的放射性通过三氯乙酸溶解度和高压液相色谱进行表征。C-ANF-(4-23)(1和10微克·分钟-1·千克体重-1)导致给药的125I-ANF-(1-28)的初始血浆浓度显著剂量依赖性增加,稳态分布容积(Vss)、代谢清除率(MCR)以及血浆(Pm)中水解产物([125I]单碘酪氨酸和游离125I)的出现减少。在最高剂量时,C-ANF-(4-23)使Vss从97±12降至36±2毫升/100克体重,MCR从50±4降至12±1毫升·分钟-1·100克体重-1,Pm从初始血浆125I-ANF-(1-28)的54±8%降至11±2%。数据表明,C-ANF受体主要负责大鼠体内ANF的超大分布容积和快速MCR。通过这种方式,C-ANF受体可能在循环ANF的稳态中发挥重要作用。